文摘
Mutations in GBA, the gene encoding glucocerebrosidase, the lysosomal enzyme deficient in Gaucher disease increase the risk for developing Parkinson disease. Recent research suggests a relationship between glucocerebrosidase and the Parkinson disease-related amyloid-forming protein, ¦Á-synuclein; however, the specific molecular mechanisms responsible for association remain elusive. Previously, we showed that ¦Á-synuclein and glucocerebrosidase interact selectively under lysosomal conditions, and proposed that this newly identified interaction might influence cellular levels of ¦Á-synuclein by either promoting protein degradation and/or preventing aggregation. Here, we demonstrate that membrane-bound ¦Á-synuclein interacts with glucocerebrosidase, and that this complex formation inhibits enzyme function. Using site-specific fluorescence and F?rster energy transfer probes, we mapped the protein-enzyme interacting regions on unilamellar vesicles. Our data suggest that on the membrane surface, the glucocerebrosidase-¦Á-synuclein interaction involves a larger ¦Á-synuclein region compared to that found in solution. In addition, ¦Á-synuclein acts as a mixed inhibitor with an apparent IC50 in the submicromolar range. Importantly, the membrane-bound, ¦Á-helical form of ¦Á-synuclein is necessary for inhibition. This glucocerebrosidase interaction and inhibition likely contribute to the mechanism underlying GBA-associated parkinsonism.